News Announcement

Strides Pharma Science: Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)

We would like to inform that the Board of Directors of the Company in their meeting held on November 10 2021 have considered and approved the request received from few Promoters/ Promoter Group of the Company seeking reclassification of their shareholding from Promoters/ Promoter Group to Public category.

As required under SEBI Listing Regulations we also enclose herewith extract of Minutes of Meeting of the Board of Directors held on November 10 2021 approving such re-classification for your reference.

The Company will seek Members approval for the reclassification in line with the provisions of Regulation 31A of SEBI Listing Regulations in due course.

Request you to kindly take the same on record and oblige.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds